Publication dates

All regions

Neurological Disease Industry, October 2014 Market Research & Statistics

You might be interested in: hospital, drug, beef, more »

1-10 of about 500 reports for Neurological Disease

Pathology Description in Jordan and Iraq

  • Health and Nutrition Biweekly
  • January 2013
    5 pages
  • Pathology  

    Measles  

  • Jordan  

    Iraq  

    Lebanon  

View report >

Pathology Description in Nigeria

  • Gestational Headaches: Characteristics and Influencing Factors i...
  • January 2014
    6 pages
  • Headache  

    Neurological Di...  

  • Nigeria  

View report >

Pathology Description in Brazil

  • M Jor Article
  • April 2013
    6 pages
  • Influenza  

  • Brazil  

    South America  

View report >

Pathology Description in Colombia - Forecast

  • Risk Factors and Prevalence of Osteoporosis in Premenopausal Wom...
  • January 2013
    6 pages
  • Osteoporosis  

  • Colombia  

View report >

Pathology Industry - Analyst Report, 2014

  • Nyloxin® Relief
  • January 2014
    7 pages
  • Pathology  

  • United States  

View report >

Pathology Description in India

  • Clinical Profile of Neurological Complications in Hivreactive Pa...
  • August 2014
    10 pages
  • Hiv  

  • India  

View report >

Beef Imports in South Korea and the US

  • Korea's Demand for U.s. Beef
  • January 2013
    17 pages
  • Beef  

  • South Korea  

    United States  

    Asia  

View report >

Pathology Description in the US

  • Diabetes & Metabolism
  • January 2014
    6 pages
  • Diabete  

    Chronic Conditi...  

    Endocrine, Nutr...  

  • United States  

View report >

Analyst Report, August 2014

  • Small-cap Research
  • August 2014
    9 pages
  • United States  

    Europe  

View report >

Drug And Medication Markets in the US

  • For Reprints, Links & Permissions
  • September 2014
    14 pages
  • Drug And Medica...  

  • United States  

View report >
About 18 000 reports for Neurological Disease

Purchase Reports From Reputable Market Research Publishers
(From $ 125 - $ 10 995)

KOL Insight: Multiple Sclerosis

KOL Insight: Multiple Sclerosis

  • $ 6 495
  • Industry report
  • October 2014
  • by Firstword Pharma

Recent launches of oral therapies have brought clinical advantages and clear patient benefits and are set to transform the treatment of Multiple Sclerosis (MS). The question is, which products will rise ...

Greece Epilepsy, Dalys

May 2013 $ 250

Nauru Epilepsy, Dalys

May 2013 $ 250

Belarus Epilepsy, Dalys

May 2013 $ 250

Sudan Epilepsy, Dalys

May 2013 $ 250


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.